| pubmed-article:9101493 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0040833 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0205419 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0033080 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C1710038 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C1521798 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:9101493 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:9101493 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9101493 | pubmed:dateCreated | 1997-7-24 | lld:pubmed |
| pubmed-article:9101493 | pubmed:abstractText | To evaluate practice variation and time trends in the initial prescription of second line drugs for the treatment of rheumatoid arthritis (RA) by a group of selected rheumatologists. | lld:pubmed |
| pubmed-article:9101493 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9101493 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101493 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9101493 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9101493 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:RussellA SAS | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:FitzgeraldAA | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:Suarez-Almazo... | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:Avina-Zubieta... | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:Galindo-Rodri... | lld:pubmed |
| pubmed-article:9101493 | pubmed:author | pubmed-author:LeClerqS ASA | lld:pubmed |
| pubmed-article:9101493 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9101493 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:9101493 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9101493 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9101493 | pubmed:pagination | 633-8 | lld:pubmed |
| pubmed-article:9101493 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:meshHeading | pubmed-meshheading:9101493-... | lld:pubmed |
| pubmed-article:9101493 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9101493 | pubmed:articleTitle | Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. | lld:pubmed |
| pubmed-article:9101493 | pubmed:affiliation | Department of Public Health Sciences, University of Alberta, Edmonton, Canada. | lld:pubmed |
| pubmed-article:9101493 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9101493 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9101493 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9101493 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9101493 | lld:pubmed |
